(1S,2R)-Globalagliatin

CAS No. 2514278-46-5

(1S,2R)-Globalagliatin( —— )

Catalog No. M34554 CAS No. 2514278-46-5

(1S,2R)-Globalagliatin is a highly potent glucokinase (GK) activator for the study of type 2 diabetes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 65 In Stock
10MG 95 In Stock
25MG 159 In Stock
50MG 229 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (1S,2R)-Globalagliatin
  • Note
    Research use only, not for human use.
  • Brief Description
    (1S,2R)-Globalagliatin is a highly potent glucokinase (GK) activator for the study of type 2 diabetes.
  • Description
    (1S,2R)-Globalagliatin is a highly potent glucokinase (GK) activator for the study of type 2 diabetes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Glucokinase
  • Recptor
    Glucokinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2514278-46-5
  • Formula Weight
    559.81
  • Molecular Formula
    C28H37N3O3S3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(NC=1SC(SCCN2CCCC2)=CN1)(=O)[C@@]3([C@H](C3)C4CCCCC4)C5=CC=C(S(=O)(=O)C6CC6)C=C5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • SF2312

    SF2312 is a natural phosphonate antibiotic produced by Actinobacillus microsporus and is a potent inhibitor of the glycolytic enzyme enolase.

  • XL388

    XL388 is a highly effective, specifc, ATP-competitive inhibitor of mTOR ( IC50: 9.9 nM), 1000-fold selectivity than the closely related PI3K kinases.

  • 3PO

    3PO is a small-molecule inhibitor of PFKFB3 (IC50: 22.9 μM), inhibiting the proliferation of several human malignant hematopoietic and adenocarcinoma cell lines (IC50: 1.4-24 μM).